Derivatives of 4-(thioor selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-ht?2b? receptor antagonist

Details for Australian Patent Application No. 2002350603 (hide)

Owner Biofrontera Pharmaceuticals GmbH

Inventors Froimowitz, Mark; Ullmer, Christoph; Gordon, Douglas; Bellott, Emile; Lubbert, Hermann

Agent Griffith Hack

Pub. Number AU-B-2002350603

PCT Number PCT/EP02/11817

PCT Pub. Number WO2003/035646

Priority 01125527.0 25.10.01 EP

Filing date 23 October 2002

Wipo publication date 6 May 2003

Acceptance publication date 28 February 2008

International Classifications

C07D 409/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

A61K 31/4523 (2006.01) - containing further heterocyclic ring systems

A61K 31/4535 (2006.01)

A61K 31/473 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines

A61P 1/00 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/12 (2006.01) Drugs for disorders of the cardiovascular system

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 13/08 (2006.01) Drugs for disorders of the urinary system

A61P 15/00 (2006.01) Drugs for genital or sexual disorders

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/06 (2006.01) Drugs for disorders of the nervous system

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 421/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having selenium, tellurium, or halogen atoms as ring hetero atoms

Event Publications

20 March 2003 Complete Application Filed

  Priority application(s): 01125527.0 25.10.01 EP

3 July 2003 Application Open to Public Inspection

  Published as AU-B-2002350603

28 February 2008 Application Accepted

  Published as AU-B-2002350603

26 June 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002350604-Exponential pattern recognition based cellular targeting, compositions, methods and anticancer applications

2002350602-AN OFFSET PRINTING PRESS